BIODESIX, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BIODESIX, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $8.00K.
- BIODESIX, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $1.00K.
- BIODESIX, INC. stock issued during period, value, stock options exercised for the quarter ending 2024-09-30 was $12.00K, a 300.00% increase year-over-year.
- BIODESIX, INC. stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was $4.00K, a 95.06% decline year-over-year.
- BIODESIX, INC. stock issued during period, value, stock options exercised for fiscal 2024 was $24.00K, a 73.63% decline from fiscal 2023.
- BIODESIX, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $91.00K, a 66.17% decline from fiscal 2022.
- BIODESIX, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $269.00K, a 65.02% decline from fiscal 2021.
- BIODESIX, INC. stock issued during period, value, stock options exercised for fiscal 2021 was $769.00K, a 42.61% decline from fiscal 2020.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $8.00K 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $1.00K 10-Q · filed 2026-08-05 | |
| 2024-12-31 | $24.00K 10-K · filed 2026-02-26 | |
| 2024-09-30 | $12.00K 10-Q · filed 2025-11-03 | |
| 2024-06-30 | $4.00K 10-Q · filed 2025-11-03 | |
| 2024-03-31 | $3.00K 10-Q · filed 2025-11-03 | |
| 2023-12-31 | $91.00K 10-K · filed 2025-03-03 | |
| 2023-09-30 | $3.00K 10-Q · filed 2024-11-01 | |
| 2023-06-30 | $81.00K 10-Q · filed 2024-11-01 | |
| 2023-03-31 | $6.00K 10-Q · filed 2024-11-01 | |
| 2022-12-31 | $269.00K 10-K · filed 2024-03-01 | |
| 2022-09-30 | $57.00K 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $17.00K 10-Q · filed 2023-11-07 | |
| 2022-03-31 | $75.00K 10-Q · filed 2023-11-07 | |
| 2021-12-31 | $769.00K 10-K · filed 2023-03-06 | |
| 2021-09-30 | $60.00K 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $204.00K 10-Q · filed 2022-11-03 | |
| 2021-03-31 | $475.00K 10-Q · filed 2022-11-03 | |
| 2020-12-31 | $1.34M 10-K · filed 2022-03-14 | |
| 2020-09-30 | $14.00K 10-Q · filed 2021-11-15 | |
| 2020-03-31 | $11.00K 10-Q · filed 2021-11-15 | |
| 2019-12-31 | $47.00K 10-K · filed 2021-03-16 | |
| 2019-09-30 | $16.00K 10-Q · filed 2020-12-10 | |
| 2019-06-30 | $1.00K 10-Q · filed 2020-12-10 | |
| 2019-03-31 | $30.00K 10-Q · filed 2020-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |